Effectiveness and Safety Evaluation of Aqueduct 100-device
Status unconfirmed · Not applicable
Conditions studied: Cervix Uteri Dilation
In brief
Evaluation of efficacy and safety of using Aqueduct -100 - Cervical Dilator Device, focusing on diagnostic or operative hysteroscopies.
Key facts
- Study ID
- NCT02959567
- Run by
- Aqueduct Medical Ltd
- People needed
- 100
- Starts
- 2016-11-01
- Expected to finish
- 2017-10-01
- Last updated by the study team
- 2016-11-09
Who can join
Age: 18 and older. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- Subjects, females, 18 years of age or older.
- Subjects undergoing diagnostic or operative hysteroscopies
- Subjects willing to sign informed consent form.
You may not qualify if…
- Subjects younger than 18 years of age
- Subjects unwilling to sign the informed consent form
- Pregnancy
Where it is running
- Baptist Medical Arts Surgical Center, Gynecology Department — Miami, Florida, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.